BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69:661-668. [PMID: 24582176 DOI: 10.1016/j.crad.2014.01.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Atman ED, Erden A, Uzun Ç, Yavuz Y. Additional Diagnostic Value of Inversion Recovery Single-Shot Fast-Spin Echo Sequence in Differentiation Between Hepatic Hemangiomas and Cysts. J Comput Assist Tomogr 2015;39:483-8. [PMID: 25955398 DOI: 10.1097/RCT.0000000000000257] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Iwaki S, Hokamura K, Ogawa M, Takehara Y, Muramatsu Y, Yamane T, Hirabayashi K, Morimoto Y, Hagisawa K, Nakahara K, Mineno T, Terai T, Komatsu T, Ueno T, Tamura K, Adachi Y, Hirata Y, Arita M, Arai H, Umemura K, Nagano T, Hanaoka K. A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques. Org Biomol Chem 2014;12:8611-8. [DOI: 10.1039/c4ob01270d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nguyen KL, Yoshida T, Kathuria-Prakash N, Zaki IH, Varallyay CG, Semple SI, Saouaf R, Rigsby CK, Stoumpos S, Whitehead KK, Griffin LM, Saloner D, Hope MD, Prince MR, Fogel MA, Schiebler ML, Roditi GH, Radjenovic A, Newby DE, Neuwelt EA, Bashir MR, Hu P, Finn JP. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI. Radiology 2019;293:554-64. [PMID: 31638489 DOI: 10.1148/radiol.2019190477] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
4 Jehn U, Schuette-Nuetgen K, Kentrup D, Hoerr V, Reuter S. Renal Allograft Rejection: Noninvasive Ultrasound- and MRI-Based Diagnostics. Contrast Media Mol Imaging. 2019;2019:3568067. [PMID: 31093027 DOI: 10.1155/2019/3568067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khant ZA, Azuma M, Kadota Y, Hattori Y, Takeshima H, Yokogami K, Watanabe T, Enzaki M, Nakaura T, Hirai T. Evaluation of pituitary structures and lesions with turbo spin-echo diffusion-weighted imaging. J Neurol Sci 2019;405:116390. [PMID: 31476623 DOI: 10.1016/j.jns.2019.07.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Mukundan S, Steigner ML, Hsiao LL, Malek SK, Tullius SG, Chin MS, Siedlecki AM. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD. Am J Kidney Dis 2016;67:984-8. [PMID: 26786296 DOI: 10.1053/j.ajkd.2015.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
7 Moshiri AS, Elenitsas R, Gaddis KJ, Werth VP, Nguyen CV, Pearson D, Rubin AI. Launching lollipops? Perforating osteoma cutis in nephrogenic systemic fibrosis. J Cutan Pathol 2019;46:467-70. [DOI: 10.1111/cup.13409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Thakor AS, Tanner J, Ong SJ, Hughes-Roberts Y, Ilyas S, Cousins C, See TC, Klass D, Winterbottom AP. Radiological Evaluation of Abdominal Endovascular Aortic Aneurysm Repair. Can Assoc Radiol J 2015;66:277-90. [PMID: 25978867 DOI: 10.1016/j.carj.2014.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Bruce R, Wentland AL, Haemel AK, Garrett RW, Sadowski DR, Djamali A, Sadowski EA. Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Invest Radiol. 2016;51:701-705. [PMID: 26885631 DOI: 10.1097/rli.0000000000000259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
10 Ramalho M, Ramalho J, Burke LM, Semelka RC. Gadolinium Retention and Toxicity—An Update. Advances in Chronic Kidney Disease 2017;24:138-46. [DOI: 10.1053/j.ackd.2017.03.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
11 Zhu J, Gale EM, Atanasova I, Rietz TA, Caravan P. Hexameric Mn(II) dendrimer as MRI contrast agent. Chemistry 2014;20:14507-13. [PMID: 25224391 DOI: 10.1002/chem.201403883] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
12 Abdelgawad MS, Aly RA. Value of susceptibility-weighted MR imaging (SWI) in the detection of developmental venous anomaly. Egypt J Radiol Nucl Med 2020;51. [DOI: 10.1186/s43055-020-00216-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Deshayes S, de Boysson H, Geffray L. Les syndromes sclérodermiformes. La Revue de Médecine Interne 2016;37:616-24. [DOI: 10.1016/j.revmed.2015.12.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Dweck MR, Williams MC, Moss AJ, Newby DE, Fayad ZA. Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease. J Am Coll Cardiol 2016;68:2201-16. [PMID: 27855810 DOI: 10.1016/j.jacc.2016.08.047] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
15 Kim HK, Lee GH, Chang Y. Gadolinium as an MRI contrast agent. Future Med Chem 2018;10:639-61. [PMID: 29412006 DOI: 10.4155/fmc-2017-0215] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
16 Wagner M, Knobloch G, Gielen M, Lauff M, Romano V, Hamm B, Kröncke T. Nonenhanced peripheral MR-angiography (MRA) at 3 Tesla: evaluation of quiescent-interval single-shot MRA in patients undergoing digital subtraction angiography. Int J Cardiovasc Imaging 2015;31:841-50. [DOI: 10.1007/s10554-015-0612-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
17 Casterou  G, Collière V, Lecante P, Coppel Y, Eliat P, Gauffre F, Kahn ML. Improved Transversal Relaxivity for Highly Crystalline Nanoparticles of Pure γ-Fe 2 O 3 Phase. Chem Eur J 2015;21:18855-61. [DOI: 10.1002/chem.201502905] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Semelka RC, Commander CW, Jay M, Burke LM, Ramalho M. Presumed Gadolinium Toxicity in Subjects With Normal Renal Function: A Report of 4 Cases. Invest Radiol 2016;51:661-5. [DOI: 10.1097/rli.0000000000000318] [Cited by in Crossref: 52] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
19 Baez JC, Seethamraju RT, Mulkern R, Ciet P, Lee EY. Pediatric Chest MR Imaging: Sedation, Techniques, and Extracardiac Vessels. Magn Reson Imaging Clin N Am 2015;23:321-35. [PMID: 25952523 DOI: 10.1016/j.mric.2015.01.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Gao S, George SJ, Zhou Z. Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis. Dalton Trans 2016;45:5388-94. [DOI: 10.1039/c5dt04172d] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Seo N, Park SH, Kim KJ, Kang BK, Lee Y, Yang SK, Ye BD, Park SH, Kim SY, Baek S, Han K, Ha HK. MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study. Radiology. 2016;278:762-772. [PMID: 26348103 DOI: 10.1148/radiol.2015150809] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
22 Gale EM, Atanasova IP, Blasi F, Ay I, Caravan P. A Manganese Alternative to Gadolinium for MRI Contrast. J Am Chem Soc 2015;137:15548-57. [PMID: 26588204 DOI: 10.1021/jacs.5b10748] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 20.4] [Reference Citation Analysis]
23 Erdene K, Nakajima T, Kameo S, Khairinisa MA, Lamid-ochir O, Tumenjargal A, Koibuchi N, Koyama H, Tsushima Y. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents. Jpn J Radiol 2017;35:568-73. [DOI: 10.1007/s11604-017-0667-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
24 Murphy DJ, Kwong RY. Contrast Agents in Cardiovascular Magnetic Resonance Imaging. In: Kwong RY, Jerosch-herold M, Heydari B, editors. Cardiovascular Magnetic Resonance Imaging. New York: Springer; 2019. pp. 127-43. [DOI: 10.1007/978-1-4939-8841-9_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Liang KW, Chen JW, Huang HH, Su CH, Tyan YS, Tsao TF. The Performance of Noncontrast Magnetic Resonance Angiography in Detecting Renal Artery Stenosis as Compared With Contrast Enhanced Magnetic Resonance Angiography Using Conventional Angiography as a Reference. J Comput Assist Tomogr 2017;41:619-27. [PMID: 28099225 DOI: 10.1097/RCT.0000000000000574] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
26 Wang SY, Gao S, Dai JW, Shi YR, Dong X, Weng WZ, Zhou ZH. Carbonate and phosphite encaged in frameworks constructed from square lanthanum aminopolycarboxylates and sodium chloride. Dalton Trans 2019;48:2959-66. [PMID: 30741287 DOI: 10.1039/c8dt04940h] [Reference Citation Analysis]
27 Nguyen KL, Moriarty JM, Plotnik AN, Aksoy O, Yoshida T, Shemin RJ, Suh WM, Finn JP. Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care. Radiology 2018;286:326-37. [PMID: 29040038 DOI: 10.1148/radiol.2017162899] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
28 Thölking G, Schuette-Nuetgen K, Kentrup D, Pawelski H, Reuter S. Imaging-based diagnosis of acute renal allograft rejection. World J Transplant 2016; 6(1): 174-182 [PMID: 27011915 DOI: 10.5500/wjt.v6.i1.174] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
29 Zhang B, Liang L, Chen W, Liang C, Zhang S. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One 2015;10:e0129720. [PMID: 26076348 DOI: 10.1371/journal.pone.0129720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
30 Park SH. DWI at MR Enterography for Evaluating Bowel Inflammation in Crohn Disease. AJR Am J Roentgenol. 2016;207:40-48. [PMID: 26959382 DOI: 10.2214/ajr.15.15862] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
31 Wallace A, Pershad Y, Saini A, Alzubaidi S, Naidu S, Knuttinen G, Oklu R. Computed tomography angiography evaluation of acute limb ischemia. Vasa 2019;48:57-64. [PMID: 30376423 DOI: 10.1024/0301-1526/a000759] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Ramalho M, AlObaidy M, Busireddy KK, Altun E, Liu B, Semelka RC. Quantitative and qualitative comparison of 0.025 mmol/kg gadobenate dimeglumine for abdominal MRI at 1.5T and 3T MRI in patients with low estimated glomerular filtration rate. Eur J Radiol. 2015;84:26-32. [PMID: 25467229 DOI: 10.1016/j.ejrad.2014.10.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Knobloch G, Lauff M, Hirsch S, Schwenke C, Hamm B, Wagner M. Nonenhanced magnetic resonance angiography (MRA) of the calf arteries at 3 Tesla: intraindividual comparison of 3D flow-dependent subtractive MRA and 2D flow-independent non-subtractive MRA. Eur Radiol 2016;26:4585-94. [DOI: 10.1007/s00330-016-4246-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
34 Knoepp F, Bettmer J, Fronius M. Gadolinium released by the linear gadolinium-based contrast-agent Gd-DTPA decreases the activity of human epithelial Na+ channels (ENaCs). Biochim Biophys Acta Biomembr 2017;1859:1040-8. [PMID: 28257815 DOI: 10.1016/j.bbamem.2017.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Thomsen HS. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 2. Acta Radiol 2016;57:643-8. [PMID: 26802070 DOI: 10.1177/0284185115626481] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
36 Morgan ND, Hummers LK. Scleroderma Mimickers. Curr Treatm Opt Rheumatol 2016;2:69-84. [PMID: 28473954 DOI: 10.1007/s40674-016-0038-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Shaida N, Priest AN, See T, Winterbottom AP, Graves MJ, Lomas DJ. Evaluation of velocity-sensitized and acceleration-sensitized NCE-MRA for below-knee peripheral arterial disease: NCE-MRA for Below-Knee Disease. J Magn Reson Imaging 2017;45:1846-53. [DOI: 10.1002/jmri.25533] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Pascoe VL, Fenves AZ, Wofford J, Jackson JM, Menter A, Kimball AB. The spectrum of nephrocutaneous diseases and associations. Journal of the American Academy of Dermatology 2016;74:247-70. [DOI: 10.1016/j.jaad.2015.05.042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
39 Starmans LWE, Hummelink MAPM, Rossin R, Kneepkens ECM, Lamerichs R, Donato K, Nicolay K, Grüll H. 89 Zr- and Fe-Labeled Polymeric Micelles for Dual Modality PET and T 1 -Weighted MR Imaging. Adv Healthcare Mater 2015;4:2137-45. [DOI: 10.1002/adhm.201500414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
40 Watanabe T, Frahm J. Gadobutrol enhances T1-weighted MRI of nerve cells. Toxicol Lett 2019;308:17-23. [PMID: 30902667 DOI: 10.1016/j.toxlet.2019.03.005] [Reference Citation Analysis]
41 Cahalane AM, Mojtahed A, Sahani DV, Elias N, Kambadakone AR. Pre-hepatic and pre-pancreatic transplant donor evaluation. Cardiovasc Diagn Ther 2019;9:S97-S115. [PMID: 31559157 DOI: 10.21037/cdt.2018.09.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
42 Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology (Oxford) 2018;57:iv51-60. [PMID: 29351654 DOI: 10.1093/rheumatology/kex501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
43 Deagostino A, Protti N, Alberti D, Boggio P, Bortolussi S, Altieri S, Crich SG. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications. Future Med Chem 2016;8:899-917. [PMID: 27195428 DOI: 10.4155/fmc-2016-0022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
44 Semelka RC, Ramalho M. Physicians with self-diagnosed gadolinium deposition disease: a case series. Radiol Bras 2021;54:238-42. [PMID: 34393290 DOI: 10.1590/0100-3984.2020.0073] [Reference Citation Analysis]
45 Wagner LA, Tata AL, Fink JC. Patient safety issues in CKD: core curriculum 2015. Am J Kidney Dis 2015;66:159-69. [PMID: 25987263 DOI: 10.1053/j.ajkd.2015.02.343] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
46 Bley TA, François CJ, Schiebler ML, Wieben O, Takei N, Brittain JH, Del Rio AM, Grist TM, Reeder SB. Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model. Eur Radiol 2016;26:547-55. [DOI: 10.1007/s00330-015-3833-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
47 Miyake Y, Ishikawa S, Kimura Y, Son A, Imai H, Matsuda T, Yamada H, Toshimitsu A, Kondo T. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM. Sensors (Basel) 2015;15:31973-86. [PMID: 26694418 DOI: 10.3390/s151229900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Ahmad F, Treanor L, Mcgrath TA, Walker D, Mcinnes MD, Schieda N. Safety of Off‐Label Use of Ferumoxtyol as a Contrast Agent for MRI : A Systematic Review and Meta‐Analysis of Adverse Events. J Magn Reson Imaging 2021;53:840-58. [DOI: 10.1002/jmri.27405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Chun CW, Jung JY, Baik JS, Jee WH, Kim SK, Shin SH. Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI. J Magn Reson Imaging 2018;47:60-8. [PMID: 28432835 DOI: 10.1002/jmri.25743] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
50 Haedicke IE, Loai S, Cheng HM. An Efficient T 1 Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI. Contrast Media Mol Imaging 2019;2019:3475786. [PMID: 31316306 DOI: 10.1155/2019/3475786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Murphy DJ, Aghayev A, Steigner ML. Vascular CT and MRI: a practical guide to imaging protocols. Insights Imaging 2018;9:215-36. [PMID: 29541955 DOI: 10.1007/s13244-018-0597-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
52 Armstrong L, Rodrigues J, Lawton C, Tyrell-price J, Hamilton M, Manghat N. Application of TWIST MR angiography to aid successful central venous access in challenging patients: initial single-centre experience. Clinical Radiology 2016;71:1104-12. [DOI: 10.1016/j.crad.2016.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
53 Wenham C, Grainger A, Conaghan P. The role of imaging modalities in the diagnosis, differential diagnosis and clinical assessment of peripheral joint osteoarthritis. Osteoarthritis and Cartilage 2014;22:1692-702. [DOI: 10.1016/j.joca.2014.06.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
54 Pua U, Tan CH, Ho HH, Tan JKB, Ong PJL. Revisiting renovascular imaging for renal sympathetic denervation: current techniques and applications. Eur Radiol 2015;25:444-53. [DOI: 10.1007/s00330-014-3392-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
55 Beckett KR, Moriarity AK, Langer JM. Safe Use of Contrast Media: What the Radiologist Needs to Know. RadioGraphics 2015;35:1738-50. [DOI: 10.1148/rg.2015150033] [Cited by in Crossref: 120] [Cited by in F6Publishing: 77] [Article Influence: 17.1] [Reference Citation Analysis]
56 Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:268-78. [PMID: 26757021 DOI: 10.7326/M15-1789] [Cited by in Crossref: 164] [Cited by in F6Publishing: 65] [Article Influence: 27.3] [Reference Citation Analysis]
57 Honda Y, Goto K, Sentani K, Yasui W, Ikeda K, Matsubara A, Awai K. T Categorization of Urothelial Carcinomas of the Ureter With CT: Preliminary Study of New Diagnostic Criteria Proposed for Differentiating T2 or Lower From T3 or Higher. American Journal of Roentgenology 2015;204:792-7. [DOI: 10.2214/ajr.14.13167] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
58 Ortiz J, Ruland S. Cervicocerebral artery dissection. Curr Opin Cardiol 2015;30:603-10. [PMID: 26447501 DOI: 10.1097/HCO.0000000000000224] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]